Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events: A Meta-Analysis of Randomized Clinical Trials

Objective. Data from randomized clinical trials with metabolic outcomes can be used to address concerns about potential issues of cardiovascular safety for newer drugs for type 2 diabetes. This meta-analysis was designed to assess cardiovascular safety of GLP-1 receptor agonists. Design and Methods....

Descripción completa

Detalles Bibliográficos
Autores principales: Monami, Matteo, Cremasco, Francesco, Lamanna, Caterina, Colombi, Claudia, Desideri, Carla Maria, Iacomelli, Iacopo, Marchionni, Niccolò, Mannucci, Edoardo
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092497/
https://www.ncbi.nlm.nih.gov/pubmed/21584276
http://dx.doi.org/10.1155/2011/215764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092497/
https://www.ncbi.nlm.nih.gov/pubmed/21584276
http://dx.doi.org/10.1155/2011/215764

Ejemplares similares